ABSTRACT The muscarinic acetylcholine receptor (mAChR)-stimulated, inwardly rectifying K + current (Ir4^Cal) was examined in single bullfrog atrial cells using the whole-cell patch clamp technique. Iir was activated either by bath addition of 1 /~M ACh or via activation of the G protein, Gk, with guanosine-'r-thiotriphosphate (GTP3~S). Arachidonic acid (AA) modulated IKtAC~] under both conditions. AA decreased mAChR-stimulated Ir4Aoq and increased the rate of decay from the peak current (desensitization). In addition, AA affected GTPTS-activated IK[AC~] by modulation of C~. The effects of AA and its metabolites on Gk were assessed by examining their effects on both the basal rate of Gk activation by GTPTS, and the mAChR-mediated increase in activation rate produced by nanomolar ACh. AA increased the basal rate of GTP"/S-mediated IKtxchl activation, but reduced the ACh-induced augmentation of this rate. All of the effects of AA on GTP3,Smediated IgtACa] activation were produced by metabolites. A lipoxygenase inhibitor, nordihydroguaiaretic acid (NDGA), decreased the basal and ACh-enhanced rate of IKIAChl activation in both the presence and absence of exogenous AA. In contrast, indomethacin (INDO), a cyclooxygenase inhibitor, increased the basal rate of IKtAChj activation by GTP'rS in both the presence and absence of exogenous AA, and reversed the effects of AA on the ACh-augmented basal rate. AA metabolites produced via lipoxygenase and cyclooxygenase pathways thus have opposing effects on the signal transduction pathway from mAChR to IV4ACh]. We directly tested a lipoxygenase pathway metabolite, LTC4, on GTP3,S-mediated IK[AChl activation and found that it not only overcame the inhibitory effects of NDGA, but also increased both the basal and ACh-augmented rate of Ir4Aoq activation. From these data, we propose that AA metabolites modulate the function of G k by altering its kinetic properties.
INTRODUCTION
Acetylcholine (ACh) binding to muscarinic acetylcholine receptors (mAChR) on atrial cells activates an inwardly rectifying potassium current, IKE^Chl (Gamier et al., 1978; Simmons and Hartzell, 1987) . Although it is clear that a GTP-binding protein (Gk) mediates the coupling between mAChR and the ion channel (Breitwieser and Szabo, 1985; Pfaffinger et al., 1985) , the exact nature of the coupling remains elusive.
Activation of IKtAChl by G~ has been suggested to involve the direct interaction of G k with both mAChR and the ion channel. Initial experiments (Logothetis et al., 1987; Yatani et al., 1987) demonstrated that isolated, preactivated G proteins (or activated subunits) were capable of inducing IKEAChl in excised patches of atrial cell membranes. Cytoplasmic second messengers were apparently not involved, since the channels were not activated in on-cell patches when ACh was applied to the cell, but were activated when ACh was included in the patch pipette during on-cell recording (Soejima and Noma, 1984) .
The ability to apply isolated G protein subunits to the cytoplasmic face of excised membrane patches has produced some interesting insights into G protein-mediated signal transduction. Both isolated a (for review, see Brown and Bimbaumer, 1988) and /3~, (for review, see Neer and Clapham, 1988) subunits have been shown to produce IKEAChl-like currents. The mode of action of the isolated subunits was thought to be the same: insertion of either the a or /3~, subunits into the patch membrane, and direct interaction with the IKEACal channel protein.
Although the initial reports of/37-mediated activation of IKEAChl assumed a direct interaction of the subunits with the IKtAChl channel (Logothetis et al., 1987) , it now seems clear that the /3")' subunits are mediating at least some of their effects via activation of phospholipase A 2 (PLA2). G proteins are involved in the activation of PLA2 (for review, see Burch, 1989) , and it has been suggested that in some systems, activation is mediated by/37 subunits (Jelsema and Axelrod, 1987) . Antibodies to PLA 2 block the ability of/37 subunits to activate IKtAChl in excised patches , and bath application of arachidonic acid (AA), blockers of AA metabolism, and 5-1ipoxygenase metabolites are all capable of altering IKEAChl single channel activity Kurachi et al., 1989) . Pertussis toxin did not block the ability of AA metabolites to modulate IKtAChl (Kurachi et al., 1989) , nor were inhibitors of AA metabolism able to block the GTP'yS-medlated activation of IKIAChl' suggesting that a subunits mediate IKEACal activation in the absence of the /37 pathway. Taken together, the results of experiments with exogenously applied G protein subunits suggested that IKEAC~I may be modulated by complex interactions between the a subunit and products of/3"y-activated metabolic pathways.
To dissect out the effects of AA and its metabolites on each of the components of the normal activation cascade, we used a kinetic approach which can direcdy assess the functional state of G k (Breitwieser and Szabo, 1988) . The key feature of the method is the use of high concentrations of hydrolysis-resistant GTP analogues at fixed ratios with GTP (e.g., for GTP'yS/GTP > 20/1), which results in the irreversible activation of every Gk molecule that releases its bound GDP. This process is directly reflected in the appearance of IK[ACh]-Under these special conditions, the rate of IKt^Ch] activation is likely to correspond to the rate-limiting step in the receptor-independent activation of G k, namely, GDP release (Breitwieser and Szabo, 1988; Szaho and Otero, 1989) . The kinetic approach proved to be a remarkably reproducible and sensitive assay of the state of G k, and amplified the effects of AA and its metabolites. Our results suggest that AA can modulate both the rate of mAChR-independent Gk activation and the ability of ACh to increase this rate. AA metabolites thus set the "tone" of the mAChR--ak-IKtAC~] pathway. A preliminary account of these results has appeared (Scherer and Breitwieser, 1990) .
METHODS

Solutions
HEPES-buffered Ringer solution contained (in millimolar): NaCI, 90; KCI, 2.5; MgC12, 5; CaCI2, 2.5; and HEPES, 20; pH 7.4 . For the electrophysiological experiments, 5 #M TTX and 0.5 mM CdCI~ were added to block Na § and Ca 2+ currents, respectively. Other additions to the superfusing solution are noted in the figures. Stock solutions of AA (20 mM, in ethanol) were stored in aliquots under nitrogen at -20~ Fresh aliquots were used daily. The sulfidopeptide leukotriene C 4 (LTC4) was purchased in ethanol and stored at -80~ until the day of the experiment. Aiiquots were diluted into HEPES-buffered Ringer and used within 4 h. Stock solutions of indomethacin (INDO) in ethanol and nordihydroguaiaretic acid (NDGA) in dimethylsulfoxide were made fresh daily. Neither solvent (maximal concentration, 3.0%) had any effect on GTP3'S-or ACh-stimulated IKCAChl (data not shown). The intracellular solution contained (in millimolar): K § aspartate, 80; KCI, 30; HEPES, 5; K + EGTA, 1; GTP, 0.05; MgATP, 5; pH 7.4. When present, GTP'yS was added to the intracellular solution as the Li salt.
All salts were reagent grade. All chemicals and nucleotides were obtained from Sigma Chemical Co. (St. Louis, MO) except HEPES (Ultrol) and AA (Calbiochem Corp., San Diego, CA), and LTC 4 (Cayman, Ann Arbor, MI).
Cell Dissociation
Isolated atrial cells from the bullfrog Rana catesbeiana were obtained as described by Fischmeister and Hartzell (1986) with minor modifications. Briefly, the heart was removed, rinsed in HEPES-buffered Ringer, and then perfused with 25 ml Ca~+-free Ringer solution (in millimolar): NaCI, 88.4; KCI, 2.5; MgCI~, 1.8; NaHCOs, 23.8; NaH2PO 4, 0.6; and Na § pyruvate, 2.5; fatty acid-free bovine serum albumin, 1 mg/ml; and MEM vitamins and essential amino acids, 1 #l/ml, equilibrated with 5% CO s at 28~ The heart was then perfused (at 28~ with 25 ml of a recirculating dissociation solution (Ca2+-free Ringer solution with 5 mM creatine, 50 U/ml penicillin, and 50 #g/ml streptomycin) containing 10 mg trypsin (bovine pancreas; Boehringer Mannheim Biochemicals, Indianapolis, IN) and 62.5 mg collagenase B (Clostridium histolyticum, lot 144702; Boehringer Mannheim Biochemicals). After 60-90 min the heart was placed in dissociation medium without enzymes and the atrium dissected. Cells were released by gentle agitation of the atrium in dissociation medium for 30-45 min. The myocytes were then diluted twofold with storage solution (Ca2+-free Ringer solution with 0.9 mM CaCI~; 5 mM glucose; 1 #l/ml MEM vitamins and essential amino acids; 50 U/ml penicillin; and 50 /~g/ml streptomycin). Cells remained viable for 6-8 h after isolation.
Electrophysiology
Currents were measured by the whole-cell patch clamp technique (Hamill et al., 1981) as previously described Szabo, 1985, 1988) . Patch electrodes were fabricated from square bore glass (Glass Co. of America, MiUviUe, N J) on a Flaming Brown micropipette puller (Sutter Instrument Co., San Rafael, CA) and were used without firepolishing. Junction potentials were not corrected. Voltage pulses were generated with a computer-loaded Arbitrary Waveform generator (model 75; Wavetek, San Diego, CA). The protocol for monitoring IKtAChl used sequential 250-ms steps to --90, --125, and -5 mV from the holding potential of -85 mV (with return to the holding potential between steps). Steady-state current-voltage relationships were determined by assessing the average current at the end of 250-ms voltage steps. Pulse protocols were applied to the cell continuously from the moment of patch rupture. A 5-mV hyperpolarizing step from the holding potential was included in all pulse protocols to allow continuous monitoring of the pipette series resistance, which was not electronically compensated. Currents were measured with a patch clamp amplifier (EPC-7; List, Darmstadt-Eberstadt, FRG) and monitored with an oscilloscope (model 310; Nicolet Instrument Corp., Madison, WI). Signals were converted to digital signal via a PCM-1 instrumentation adaptor (Medical Systems Corp., Greenvale, NY) and stored on VCR tape (VHS, model AG-1230; Panasonic, Secaucus, NJ). Rates were estimated by recording the analogue signal on either an Astromed (model Z100; Astromed, West Warwick, RI) or Gould recorder (model 220; Gould Inc., Cleveland, OH). All experiments were performed at room temperature (22-24~
RESULTS
AA Alters Both the Magnitude and Time Course of lr4aC~l Activation
ACh induces an inwardly rectifying K + current in isolated bullfrog atrial myocytes, as illustrated by the steady-state current-voltage relationship shown in Fig. 1 A. To assess whether AA could activate whole-cell IKt^czl to a level comparable to that obtained with ACh, we superfused bullfrog atrial cells with 20 #M AA. AA produced minimal activation of Ix~E^ca] (Fig. 1 B) : in this particular experiment, there was a 3-pA increase in outward current at -5 inV.
Also illustrated in Fig. 1 B is the response of the myocyte to ACh in the continued presence of AA. After a 2-rain exposure to 20 #M AA, stimulation with 1 #M ACh elicited a smaller current than that seen in response to ACh in the absence of AA (compare Fig. 1, A and B) . Since AA also altered the kinetics of IKEAC~J decay after ACh application (see below), the mean ACh-induced I~E^c~l in the presence of AA was assessed 30 s after the peak response and was 37.8 • 4.0 pA (SEM; n = 17) at -5 mV. This is less than half of the steady-state IKEAChl observed in the absence of AA (88.1 _+ 8.1 pA; n = 32).
AA modified the kinetics of decay of the current induced by ACh. Illustrated in Fig. 2 A is the control time course of decay of IV4AC~1 at --5 mV in response to 1 #M ACh. Application of ACh induced a peak IXqAC~j which decreased to 57 + 5% (n = 4) of peak within 1 rain. There was, in addition to the decrease in magnitude of the peak current in the presence of 20 #M AA, a more marked time-dependent decline in I~EAc~I (Fig. 2 B) . In this representative experiment, the peak IKEACh I in the presence of AA was lower than control, and IKEACal decayed to <20% of peak current within 1 min. I~[A(m] after l min of I #M ACh in the presence of 20 #M AA was only 30 + 6% of the corresponding peak IKtACN alSO measured in the presence of AA (n = 4).
The inhibitory effects of AA on Ixt^Chl induced by ACh may be due to either (a) a direct block of the open IxtACN channel by AA or a metabolite, or (b) an effect of AA on mAChR and/or Gk. The next section uses GTP~,S, a hydrolysis-resistant GTP analogue, to examine whether AA can block the Ixt^ch] channel directly.
AA Does Not Block Open l~ac~ 1
Including 1 mM GTP~,S in the electrode solution induces a slow, mAChR-independent activation of IV~ACN, which reaches a maximum, steady-state IK [ACh] in ~3 min (Breitwieser and Szabo, 1988) . Addition of 1 #M ACh does not induce additional ( Fig. 2 B) is not due to a direct block of the open Iv,4AcM channel by AA, and further implies that AA must produce its effect by modulating mAChR, Gk, and/or their interactions.
AA and Its Metabolites Modify the Rate of GTP"~S-mediated IrgaChl Activation
The physiological effects of AA can be complex since AA is rapidly metabolized via two major routes: the cyclooxygenase and lipoxygenase pathways. Blocking either pathway results in both reduced production of metabolites via the blocked pathway and enhanced production of metabolites via the unblocked pathway. We therefore examined the effects on IK[ACa] activation rates of blocking either the cyclooxygenase (with INDO) or lipoxygenase (with NDGA) pathways. We summarize our conclusions in Fig. 4 in the presence of GTP'?S is used to isolate the Gk--IIqAC M interaction and to examine the effect of AA and its metabolites on the rate of GDP release by G k. The rate of IKtA~I activation induced by hydrolysis-resistant guanine nucleotides (GXP) depends only on the ratio of GXP/GTP for GXP concentrations >0.1 mM. At high ratios (>-20/1 for GTP~,S) the maximal basal IKt^cal activation rate has been shown to be equivalent to the rate of release of GDP from G k (Breitwieser and Szabo, 1988; Szabo and Otero, 1989) , and is of the order of 0.3 rain -1. The results of the previous section demonstrate that AA does not alter IKEACa] once G k has been fully activated by GTP~'S, implying that the channel itself is not blocked by AA. Thus, it is possible to use the rate of IKtAC~] activation to assess whether AA or its metabolites can affect the activation of Gk by GTP3,S, or the interaction of Gk-GTP'yS with the channel. The tabulated data are illustrated in Fig. 5 . With a ratio of 20/1 of GTP3,S/GTP (1 mM GTP3,S/50 #M GTP), the IKtAC~I activation rate was 0.28 -+ 0.02 min -1 (SEM; n = 18), as has been shown previously (Breitwieser and Szabo, 1988) . In the presence of 20 #M AA this rate was significantly increased to 0.47 _+ 0.03 min -1 (n ----24). Similar results were obtained in the presence of 10 #M atropine (control, 0.27 -+ 0.03, n = 3; 20 #M AA, 0.44 _+ 0.05, n = 5), implying that AA does not produce its effect by binding to the agonist site of mAChR. While an effect of AA on unoccupied mAChR cannot be ruled out, it is more likely that the ability of AA to increase the basal rate of IK[AChl activation by GTP3,S may be ascribed to either an effect of AA (or its metabolites) on the release of GDP from Gk or to an enhancement of the ability of activated G k to interact with the channel.
Also illustrated in pointed out that NDGA reduced the magnitude of IKtAC~] elicited by either ACh or GTP3,S (data not shown). However, since the rate of GTP~,S-mediated IKtAC~] activation was always normalized to the final ACh-stimulated IKtAC~I,~ in the same cell (as illustrated by the control activation rate in Fig. 3 ), the rates are directly comparable with those measured in the absence of NDGA. These data suggest that normal cellular AA metabolism must contribute to the ability of G k to release GDP and become activated. This is suggested by both the effects of NDGA and INDO on basal /K[AChl activation rates in the absence of exogenous AA, and by the fact that the effects of the inhibitors are the same in the presence of exogenous AA. Furthermore, the data imply that metabolites produced by both the cyclooxygenase and lipoxygenase pathways modulate Gk: lipoxygenase metabolites appear to enhance the rate of Gk activation, while cyclooxygenase metabolites appear to inhibit it.
To confirm this hypothesis, we examined the effects of a 5-1ipoxygenase metabolite, LTC4, on the rate of Ia[A~l activation by GTP'?S, in the presence and absence of either NDGA or INDO. LTC 4 was chosen for two reasons: (a) it had been shown to produce IKtAChl single channel activity Kurachi et al., 1989) and (b) it is the sulfidopeptide leukotriene that gives rise to a variety of further metabolites, allowing isolation of one branch of the 5-1ipoxygenase metabolite cascade. 10 #M LTC 4 in the absence of ACh had only a minor effect on whole-cell IK [ACh] in the presence of GTP (<2 pA at -5 mV), but it gready accelerated the basal rate of GTP3,S-mediated IK [ACh] activation, as illustrated in Fig. 5 . Significandy, NDGA did not block the stimulatory effect of LTC 4. INDO on the other hand acted synergistically with LTC4, producing a rate of IgtA~] activation 10-fold higher than that seen under control conditions. These results are consistent with products of AA metabolism mediating opposing effects on the rate of GTP3~S-mediated IK[A~] activation, and hence on the rate of GDP release from G k. 
AA and Its Metabolites Modulate the mAChR-induced Increase in the Rate of GTP~S-mediated Ir4aC~l Activation
Nanomolar concentrations of ACh, which do not activate appreciable IK [ACh] in the absence of GTP3,S, lead to a marked acceleration of the rate of GTP3,S-mediated Ir4ACh] activation (Breitwieser and Szabo, 1988) . This is consistent with the notion that mAChR activation enhances the rate of GDP release from Gk, and reflects the mAChR-G k interaction. Fig. 6 illustrates the action of 5 nM ACh on the rate of activation of IV4ACh] at high GTP3,S/GTP (20/1). The current was sampled at -5 mV from a holding potential of -85 mV starting immediately after breaking into the cell. GTP3,S (1 mM) in the pipette quickly began to diffuse into the cell and IKt^Chl began to activate at the mAChR-independent rate. The superfusing solution was then switched to one containing 5 nM ACh, causing an abrupt increase in the rate of IK [ACh] activation. IK [AC~] ,, Was then assessed by switching to a Ringer solution containing 1 #M ACh. In this cell, 5 nM ACh had already induced the maximal IKtA~] and 1 #M ACh thus had no further effect. Both the basal and the AChaugmented rates were normalized to this maximal IK[AChl," In this particular cell the rates were 0.23 and 5.07 min -1, respectively. We examined the effects of AA and its metabolites on the ACh-induced increase in the rate of activation of IK [AC~] . AA, metabolites, and/or blockers were present from the moment of patch rupture, and various ACh concentrations were applied as described above.
We first examined the effects of LTC 4 on ACh-augmented IK[AChl activation, since its effects on the basal rate of IK[ACZ] activation were purely stimulatory. Confirming a previous study (Breitwieser and Szabo, 1988) , ACh over the range from 1 to 10 nM produced an enhancement of the rate of GTP~,S-mediated IK [ACh] activation. LTC4, which stimulated the basal rate of IK [^Ch] activation by GTP~/S, also enhanced the ACh-mediated increase in this rate (Fig. 7) . This effect of LTC 4 was not altered by the presence of 10 #M NDGA, although NDGA by itself virtually prevented the activation of IK [ACZ] , even in the presence of 10 nM ACh. The ability of LTC4 to overcome the block by NDGA suggests that NDGA is specifically inhibiting metabolism via lipoxygenases (and preventing production of a required activating metabolite), rather than interacting nonspecifically with either m_AChR or the channel. The effects of exogenously applied AA are more complex than those of LTC4, since both stimulatory and inhibitory metabolites are produced, as suggested by the results in Fig. 5 . To simplify an examination of the data, the effects of NDGA and INDO on the ACh-augmented rate of la [^Ch] activation in the presence of exogenous AA are displayed separately. 20 #M AA (Fig. 8 A) produced a rightward shift in the activation curve as compared with the control (in contrast to its stimulatory effect on mAChRindependent IKt^Ch] activation rates in Fig. 5) . 10 #M NDGA, as discussed above, virtually blocked the enhancement of Ir4ACh] activation rate produced by ACh, and AA was not able to overcome this block. These results suggest that inhibitory metabolites (cyclooxygenase pathway) have a greater effect on the ACh-mediated rate of IKt^tm] activation than on the mAChR-independent basal rates.
10 #M INDO (Fig. 8 B) , by blocking utilization of exogenously applied AA via the cyclooxygenase pathway, produced an ACh-augmented rate of IK[AO~I activation which was not significantly different from control. Neither INDO + AA nor INDO alone was able to shift the ACh-mediated activation curve to the level of LTC 4, suggesting that the normal ACh-mediated augmentation of the IK[ACh] activation rate (in the absence of any exogenous lipid metabolites or blockers) is limited by cellular production of stimulatory metabolites, such as LTC 4. The ACh-induced augmentation of the IK [ACh] activation rate in the absence of exogenous AA metabolites represents the maximal rate at which LTC 4 or its further metabolites can be produced. Only when exogenous LTC4 is added to the superfusing solution do the activation curves shift to the left of control, implying that cellular metabolism, under these conditions, is rate limiting. The results further suggest that significant levels of the inhibitory metabolite(s) are not produced unless exogenous AA is provided. An excess of AA saturates the lipoxygenase pathways and results in the production of metabolites via the cyclooxygenase pathway, which apparently has a lower affinity for AA than the lipoxygenase pathway.
DISCUSSION
In this paper we present evidence that AA metabolites modulate the ACh-stimulated K + channel of bullfrog atrial cells by altering the function of the signal-transducing, GTP-binding protein, G k, which couples mAChR to the ion channel. AA ( 
Metabolism of AA Is Required
Modulation of ion channel function by AA can proceed via either a direct mechanism Ordway et al., 1989; Vacher et al., 1989) or through the production of metabolites (Piomelli et al., 1987; Kurachi et al., 1989) . To assess the contribution of each of these possibilities to the effects of AA on IKfACh] activation, we (a) examined the effects of the metabolic inhibitors NDGA and INDO on the response to AA, and (b) tested whether AA metabolites could overcome the blocking effects of the inhibitors. Virtually all of the effects of AA on IK [ACh] activation arc mediated by AA metabolitcs. Both inhibitory and stimulatory metabolites are produced (as discussed below; see also Fig. 4) . The effect of AA on the basal activation rate was blocked by NDGA to a level not statistically different from that found in the presence of NDGA alone (0.24 rain -1 [AA + NDGA] vs. 0.21 rain -1 [NDGA alone]). If the block of the basal rate of activation of IKtACh] by NDGA results in a residual rate that is due to direct effects of AA, then this effect is saturated by cellular AA levels, since addition of 20 #M exogenous AA did not significantly increase this rate, suggesting that all of the effects of AA are due to metabolites.
Lipoxygenase Metabolites Increase the Rate of IK[ACal Activation
NDGA blocks lipoxygenases, and when added to the bath in the presence or absence of exogenous AA, decreases both the basal and ACh-augmented rate of IK [ACh] activation. NDGA reduced the amplitude of IK[ACh] activated via either ACh (+ GTP) (Scherer and Breitwieser, unpublished observations) or GTP3,S (see Fig. 9 A) . All of the effects of NDGA are reversed by the 5-1ipoxygenase product, LTC4. These results strongly suggest that products of the 5-1ipoxygenasc pathway, specifically sulfidopcptide leukotrienes, enhance the rate of Gk activation. The specific metabolitcs of NDGA-blockable pathways that modulate G k are not known since NDGA blocks not only 5-1ipoxygenase, but also 12-1ipoxygenase and epoxygenases (Needleman et al., 1986; Capdevila et al., 1988) . Although we find that LTC 4 reverses the effect of NDGA, other leukotrienes or metabolites may be equally effective, since LTC4 breaks down readily to LTD4, LTE4, etc.
Cydooxygenase Metabolites Decrease the Rate of Irdacal Activation
INDO, a cyclooxygenase inhibitor, consistently increased both the basal rate of IK [ACh] activation in either the absence or presence of exogenously applied AA, and reversed the inhibitory effect of AA on the ACh-mediated augmentation of the basal activation rate. These results are consistent with the notion that a metabolite of the cyclooxygenase pathway slows the rate of G k activation. A complication is that diversion of AA into the lipoxygenase pathways may occur upon cyclooxygenase blockade (Aehringhaus et al., 1984) , thus producing more of the stimulatory metabolites. Two of our results rule out diversion of AA into the stimulatory lipoxygenase pathway as the sole explanation for the effects of INDO and argue for the production of an inhibitory metabolite: first, INDO reverses the inhibition of the ACh-augmented IK [ACa] activation rate mediated by exogenously applied AA; and second, INDO greatly potentiates the effect of exogenously applied LTC 4. The cyclooxygenase metabolite(s) that inhibit I~ACh] activation are unknown since prostaglandins, thromboxanes, and 12-hydroxy-heptadecatrienoic acid are all produced via this pathway. Experiments to identify the cyclooxygenase pathway metabolites that inhibit Gk activation are underway. 
Mechanism of Action of AA Metabolites
Our data would suggest that both lipoxygenase and cyclooxygenase products of AA modulate IKtACM through G k. Three configurations of a receptor-G protein-effector sigual-transducing pathway could account for our data, as diagrammed below, with LTR representing a leukotriene receptor, LT representing an unspecified leukotriene, and PGH2X representing one or more of the metabolites produced from prostaglandin H 2 (PGH2) via the cyclooxygenase pathway, which negatively modulate the effects of LTR. Model 1 assumes mAChR and LTR converge at G k, with both receptors capable of increasing the rate of GDP release from G k. Model 2 differs from model 1 in that mAChR and LTR interact with distinct G proteins, both of which are capable of activating IKtACh], and thus the two pathways converge at the level of the channel. Model 3 states that metabolites of AA alter the kinetic properties of G k and affect its interactions with mAChR and/or the ion channel. Models 1 and 2 assume that the relevant LTR is coupled to a G protein. proteins (Hogaboom et al., 1983) . If the relevant LTR is coupled to a G protein, it cannot be Gk, since the effect of leukotrienes on single-channel IKtACh] activation was not blocked by pertussis toxin (PTX) treatment (Kurachi et al., 1989) , which interferes with the interaction of receptors with G k (Pfaffinger et al., 1985) . Model 1 is thus ruled out. Model 2 is still plausible if it is assumed that Gk2 is not sensitive to PTX, and hence is not uncoupled from LTR by PTX treatment.
Agonists for G protein--coupled receptors act to enhance GDP release from inactive G proteins. Once the G protein becomes activated with GTP~'S, removal of agonist (e.g., ACh) is without effect Szabo, 1985, 1988) . Similarly, removal of lipoxygenase products by addition of NDGA should be without effect if the leukotrienes are acting only by increasing the rate of GDP release from G k via a classical receptor-G protein interaction. Fig. 9 illustrates the test of these predictions. In all three panels, lxtach~ was maximally activated by GTP',/S. NDGA was able to block the GTP'yS-activated IKEacal (Fig. 9 A) . Addition of ACh with NDGA did not overcome the effect of NDGA (Fig. 9 B) . LTC4, however, if added at the same time as NDGA, was able to prevent the inhibition of the GTP-yS-activated II~AChj (Fig.  9 C) , and indeed, resulted in a slight increase in the level of GTP'yS-activated current. These results further rule out models 1 and 2, since in both cases one would expect uncoupling of all of the receptors from their respective G proteins once the G proteins had been activated by GTP~'S.
Model 3 is the most parsimonious explanation of our data. We suggest that both lipoxygenase and cyclooxygenase metabolites directly modulate the functional state of G k. These metabolites produce their effects on both the inactive, GDP-bound form of G k and on ak-GTPTS, suggesting that the ot subunit is modified. Modulation of GTPTS-activated IKEACal by AA metabolites requires that either (a) the channelassociated ak-GTP-rS can still be modulated by AA metabolites or (b) there is a finite amount of dissociation of ak-GTP'yS from the ion channel during steady-state current activation. The ability of LTC 4 to increase steady-state, GTPTS-activated I~:tA~l (Fig. 9 C) suggests it is able to promote ak-GTPTS -channel association:
ak-GTPyS + channel LTC~ channel 9 ak-GTPyS, implying that both unassociated ak-GTP~rS and ion channels exist under steady-state conditions. LTC 4 could thus increase the steady-state, GTP-yS-activated IKt^Chl by shifting the equilibrium in favor of channel 9 otk-GTP3,S. This has implications for the physiological activation of IIqAC~1 by ACh. As illustrated in Fig. 2 A, peak IKtACh~ desensitizes to the steady-state current within the first 60 s after ACh application, implying that not all of the available ion channels are active during the steady state. Thus, both the net ability of Gk to activate l~r J and desensitization may, in part, be the result of alterations in the balance of inhibitory and stimulator,/AA metabolites with time after mAChR activation.
It is necessary to rule out direct modifications of either the ion channel or mAChR by AA metabolites. Several lines of evidence suggest that the ion channel is not directly blocked or modulated by AA metabolites. Fig. 3 suggests that the GTPySactivated current is not directly modulated by AA, and the results of Fig. 9 , A and C suggest that NDGA does not produce its effects by directly blocking the ion channel, since LTC 4 is able to overcome the blocking effects.
Our results rule out the mAChR as the major locus of AA metabolite action. While AA decreases the binding of the muscarinic antagonist [SH]quinuclidinylbenzilate to cardiac (Rauch et al., 1989) or synaptic membranes (Aronstam et al., 1977) , it has also been reported to increase binding of the muscarinic agonist carbamylcholine (Baron and Kloog, 1984) . Our results exclude an effect of AA or its metabolites at the agonist-binding site of mAChR binding, since AA has the same effect(s) on the rate of IKtAChl activation in the absence or presence of atropine (10 #M). In addition, the effects of AA metabolites and blockers on the ACh-augmented rate of llqAChl activation can be predicted from their effects on the basal rate of G k activation, suggesting that mAChR is interacting normally with an altered G k. Finally, AA metabolites affect the GTP~S-activated IKt^Ch] (Fig. 9) under conditions in which mAChR is uncoupled from G k. Thus, although we cannot at this time rule out a minor effect of AA and/or its metabolites on mAChR, our data would suggest that the primary site of action for AA and its metabolites is at the level of G k.
It is of interest to speculate about the ways in which G k could be modified by AA and its metabolites. There have been reports of phosphorylation of G i in response to protein kinase C activation (Katada et al., 1985) . In addition, there is evidence that hydroperoxy acids decrease the activity of the calcium-calmodulin protein kinase II (Piomelli et al., 1989) . Therefore, it is possible that a tonic level of phosphorylation of G k is modulated by AA and its metabolites. It is also possible that some other type of dynamic covalent modification of G k occurs in response to the balance of stimulatory and inhibitory metabolites of AA that are present in the membrane. Myristoylation (Buss et al., 1987; James and Olson, 1989a) , palmitoylation (James and Olson, 1989b) and farnesylation (Casey et al., 1989; Hancock et al., 1989 ) have all been described as regulated modifications of eukaryotic proteins, including ras (WiUumsen et al., 1984; Magee et al., 1987) . Such lipid-mediated covalent modifications may be the reason that cloned G i subtypes are much less potent at promoting activation of IKtACh] than biochemically purified, native G proteins (Yatani et al., 1988) . Alternately, some type of noncovalent interaction of AA metabolites or further products with G k may occur.
Comparison with Excised Patch Results
Our data confirm and extend the results of and Kurachi et al. (1989) : both groups have reported that AA and various lipoxygenase metabolites are capable of stimulating single-channel IKtAC~], although not to the same extent as GTP3,S. Our results confirm the submaximal stimulation of IlqACh] by AA at the whole-cell level: 20 #M AA induced only 2-4 pA of IKEACh], compared with 88.1 pA inducible by ACh. The inability of AA to maximally activate whole-cell IKtAChJ in the absence of ACh, the attenuation of ACh-induced II~[AChl by AA (Fig. 2) , and the influence of AA and metabolites on the rate of G k activation (e.g., Fig. 5 ) suggest that AA and metabolites play a modulatory role in IK[AO,] activation. Both Kurachi et al. (1989) and have demonstrated stimulatory effects of lipoxygenase metabolites. Kurachi et al. (1989) concluded that these metabolites either enhance GDP/GTP exchange of Gk in a receptor-independent manner, or that they couple directly to the channel via membrane receptors interacting with PTX-insensitive G proteins. Our results demonstrate that lipoxygenase metabolites increase the GDP release rate from G k and thus modulate IKEACh]. Our data also provide an explanation for the observation of Kurachi et al. (1989) of the slight stimulatory effect of INDO on single-channel IKEAChl. Since cyclooxygenases are present in endoplasmic reticulum (Needleman et al., 1986) , one might expect a greater contribution of inhibitory metabolites in the whole-cell recording configuration. Our whole-cell data define a distinct inhibitory role for cyclooxygenase products in modulating IKEA~ ] and suggest that IKt^Ch] is dynamically regulated by the balance of stimulatory and inhibitory AA metabolites.
Physiological Implications
We have shown that metabolites of AA specifically modulate IKEAC~I and suggest that they act by altering the kinetic properties of G k. Stimulation of mAChR results in activation of IKtAC~1, inhibition of adenylate cyclase, and stimulation of phosphatidylinositol metabolism. All of these effects are mediated by G proteins and thus may be subject to modulation by AA. Physiological responses to ACh such as alterations in heart rate, contractility, and conduction velocity may also be affected by AA.
The results we have obtained in the presence of exogenously applied AA may be more relevant to pathological states, in which large amounts of AA and metabolites are produced. For example, exogenously generated leukotrienes have been shown to alter cardiac performance. Leukotrienes (LTC 4 and LTD4) are produced in isolated heart preparations in response to antigenic stimulation (Aehringhaus et al., 1983; Levi et al., 1985; Yacoob and Piper, 1988) or during myocardial infarction (Evers et al., 1985) . Although all of the leukotrienes produced during pathophysiological states may not be produced by the myocytes, leukotrienes do impinge directly on cardiac muscle, probably through specific receptors (Hogaboom et al., 1985) , resulting in a negative inotropic effect (Hattori and Levi, 1984; Levi et al., 1985; Bjornsson et al., 1987) . Our data would suggest that part of the mechanism by which leukotrienes reduce myocardial contractility may be modulation of IKEAC~1, and possibly other second messenger pathways.
There also appears to be a defined role for AA metabolism under nonpathological states. The effects of NDGA and INDO on llctA~l activation rates in the absence of exogenous AA suggest that cellular metabolism of AA contributes to the normal functioning of G k and of the signal transduction pathway, which ultimately activates IKtAChJ" Since prostaglandins are produced by isolated hearts in response to muscarinic receptor stimulation (Jaiswal and Malik, 1988) , it is likely that modulation of IKEAC~I by AA metabolites occurs as a normal consequence of mAChR stimulation. Indeed, lipoxygenase products of AA metabolism may be necessary for full expression of IIqAC~I, since IKEAChl is greatly attenuated by NDGA. Finally, AA release resulting from activation of phospholipase A 2 or phospholipase C plus diacylglycerol lipase (Burch, 1989 ) via other receptor systems may modulate IKtAChl indirectly by altering Gk responsiveness to mAChR stimulation.
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